Cancer type details of overexpressed genes indicated that ANGPLT4, P4HA1, and VEGFA were mostly mutated in prostate adenocarcinoma and prostate neuroendocrine carcinoma (Figure 4). This evidence concerns the gene VEGFA and prostate neuroendocrine neoplasm.